bullish

2022 High Conviction – Medlive: Key Beneficiary of Digital Healthcare Marketing in China

Shifara has highlighted this Insight as a Top Pick
405 Views08 Dec 2021 16:07
Medlive is well positioned to benefit from growing demand for digital healthcare in China which is at an early stage. We expect Medlive to be a key beneficiary of this large addressable market.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
chart-bar
x